Search results for "survival analysi"

showing 10 items of 752 documents

External reinforcement of varicose veins with PTFE prosthesis in infrainguinal bypass surgery -- clinical results.

2003

OBJECTIVE Segmental varicose degeneration of the autogenous greater saphenous vein may limit its use in infrainguinal bypass surgery. Wrapping a PTFE prosthesis around dilated veins has emerged as an option to create externally reinforced vein bypasses. Results regarding graft patency and limb salvage were analyzed. METHODS Between September 1995 and January 2001, 35 infrainguinal bypass operations in 33 patients were performed with greater saphenous veins exhibiting segmental varicose dilatation. Grafts were followed by duplex scan and retrospective analysis of graft patency and limb salvage was performed. RESULTS One bypass prompted successful revision for early occlusion. Four bypasses r…

Pulmonary and Respiratory MedicineMaleReoperationmedicine.medical_specialtyTime FactorsPopliteal VeinLimb salvagemedicine.medical_treatmentInfrainguinal bypassGreater saphenous veinInguinal CanalProsthesisSeverity of Illness IndexTimeVaricose VeinsBlood Vessel Prosthesis ImplantationCoated Materials BiocompatibleOcclusionVaricose veinsMedicineHumansSaphenous VeinVeinPolytetrafluoroethyleneVascular PatencyAgedRetrospective StudiesAged 80 and overbusiness.industryGraft Occlusion VascularMiddle Agedmedicine.diseaseCombined Modality TherapySurvival AnalysisSurgeryRadiographyStenosismedicine.anatomical_structureTreatment OutcomeSurgeryFemalemedicine.symptomCardiology and Cardiovascular MedicinebusinessFollow-Up StudiesThe Thoracic and cardiovascular surgeon
researchProduct

Cetuximab and gemcitabine in elderly or adult PS2 patients with advanced non-small-cell lung cancer: The cetuximab in advanced lung cancer (CALC1-E a…

2009

Background:Two parallel randomized phase 2 trialswere performed to choose the optimal way of combining cetuximab with gemcitabine in the first-line treatment of elderly (CALC1-E) and adult PS2 (CALC1-PS2) patients with advanced NSCLC. Methods: Stage IV or IIIB NSCLC patients, aged ≥70 years with PS 0–2 for CALC1-E or aged <70 with PS2 for CALC1-PS2, not selected for EGFR expression,were eligible. Patients were randomized to concomitant (gemcitabine, for a maximum of 6 cycles, plus cetuximab until progression) or sequential (gemcitabine, for a maximum of 6 cycles, followed by cetuximab) strategy. A selection design, with 1-year survival rate as the primary endpoint, was applied, requiring 58…

Pulmonary and Respiratory MedicineOncologyAdultMaleCancer Researchmedicine.medical_specialtyLung NeoplasmsAdolescentSettore MED/06 - Oncologia MedicaCetuximabNSCLCAntibodies Monoclonal HumanizedDeoxycytidinelaw.inventionYoung AdultRandomized controlled triallawInternal medicineCarcinoma Non-Small-Cell LungAntineoplastic Combined Chemotherapy ProtocolsmedicineHumansLung cancerPS2 patientSurvival analysisAgedCetuximabbusiness.industryCancerAntibodies MonoclonalMiddle Agedmedicine.diseaseGemcitabineGemcitabineSurgeryClinical trialTreatment OutcomeOncologyConcomitantPatient ComplianceFemalebusinessElderly patientmedicine.drug
researchProduct

A single-institution retrospective analysis of metachronous and synchronous metastatic bronchial neuroendocrine tumors

2018

Background: Broncho-pulmonary neuroendocrine tumors (bpNETs) are rare malignancies and there is no consensus on therapeutical management of metastatic disease and follow-up after radical resection. Methods: Clinical records of patients with a cytological or histological diagnosis of bpNETs and distant metastases (metachronous or synchronous), evaluated at the European Institute of Oncology between 1997 and 2014, were retrospectively analyzed. Data on patient demographics, pathology, imaging exams, surgical and non-surgical treatments were collected. P value descriptive data, uni- and multi-variate survival analysis were generated for all variables. Results: With a median follow-up of 53 [9–…

Pulmonary and Respiratory Medicinemedicine.medical_specialtyMultivariate analysisSettore MED/06 - Oncologia MedicaPopulationDisease030204 cardiovascular system & hematologyNeuroendocrine tumorsCarcinoid tumor; Neoplasm metastasis; Neuroendocrine tumors (NETs); Recurrence; Pulmonary and Respiratory Medicine03 medical and health sciences0302 clinical medicineRecurrencemedicineeducationLymph nodeSurvival analysisNeoplasm metastasieducation.field_of_studyLungbusiness.industryCarcinoid tumormedicine.diseaseClinical trialmedicine.anatomical_structure030220 oncology & carcinogenesisOriginal ArticleNeuroendocrine tumors (NETs)Radiologybusiness
researchProduct

Radium-223 treatment in castration resistant bone metastatic prostate cancer. Should be the primary tumor always treated?

2019

Introduction: Radium-223 (223Ra) improves symptoms and survival in patients with bone metastatic castration-resistant prostate cancer (mCRPC). Study aim: To evaluate the impact of a previous radical prostatectomy (RP) on the outcome of 223Ra therapy in mCRPC patients. The primary prostate tumor left untreated could progress during 223Ra treatment. Materials and methods: mCRPC symptomatic patients treated with 223Ra were enrolled. Luteinizing Hormone-Releasing Hormone analogue was maintained. No other anticancer therapy was given. 223Ra was administered i.v. at the dose of 55 kBq/kg every 4 weeks for 6 cycles. Patients were stratified according to previous RP or not. Hematological toxicity w…

Radium-223Malemedicine.medical_specialtyUrologymedicine.medical_treatment030232 urology & nephrologyUrologyAntineoplastic AgentsBone NeoplasmsSettore MED/24 - UrologiaPrimary tumor03 medical and health sciencesProstate cancer0302 clinical medicineProstateRadium-222medicineHumansAgedProstatectomyRadiotherapybusiness.industryProstatectomyProstateChemoradiotherapy Adjuvantmedicine.diseasePrognosisRadical prostatectomyPrimary tumorSurvival AnalysisRadiation therapyProstatic Neoplasms Castration-Resistantmedicine.anatomical_structureTreatment OutcomeOncology030220 oncology & carcinogenesisConcomitantDisease ProgressionCastration resistant prostate cancerNeoplasm GradingRadiopharmaceuticalsbusinessmedicine.drugHormoneFollow-Up StudiesRadiumUrologic oncology
researchProduct

An integrated framework for risk profiling of breast cancer patients following surgery.

2006

Objective: An integrated decision support framework is proposed for clinical oncologists making prognostic assessments of patients with operable breast cancer. The framework may be delivered over a web interface. It comprises a triangulation of prognostic modelling, visualisation of historical patient data and an explanatory facility to interpret risk group assignments using empirically derived Boolean rules expressed directly in clinical terms. Methods and materials: The prognostic inferences in the interface are validated in a multicentre longitudinal cohort study by modelling retrospective data from 917 patients recruited at Christie Hospital, Wilmslow between 1983 and 1989 and predictin…

Risk profilingAdultmedicine.medical_specialtyDecision support systemMedicine (miscellaneous)Breast NeoplasmsMachine learningcomputer.software_genreModels BiologicalRisk AssessmentDecision Support TechniquesUser-Computer InterfaceBreast cancerRisk groupsArtificial IntelligencemedicineConfidence IntervalsHealth Status IndicatorsHumansMedical physicsSurvival analysisMastectomyRetrospective StudiesInternetbusiness.industryPatient SelectionReproducibility of ResultsPatient dataMiddle Agedmedicine.diseaseDecision Support Systems ClinicalPrognosisConfidence intervalTreatment OutcomeNottingham Prognostic IndexFemaleArtificial intelligenceNeural Networks ComputerbusinesscomputerMonte Carlo MethodAlgorithmsArtificial intelligence in medicine
researchProduct

Red wine extract prevents neuronal apoptosis in vitro and reduces mortality of transgenic mice.

2007

In this work, we have investigated the effects of nutritional antioxidants as antidegenerative agents on glutamate-induced apoptosis in primary cultures of cerebellar granule neurons (CGNs). Glutamate-induced apoptosis is also associated with intracellular [Ca(2+)]i overload, generation of reactive oxygen species (ROS), depression of cell energy metabolism, cytochrome c release, and increase in caspase-3 activity. Pretreatment (3 h) with red wine extract (5 microg/mL) and ascorbic acid (30 microM) blocks glutamate-induced apoptosis in CGNs. In vivo experiments carried out on transgenic mice expressing the human mutated Cu, Zn superoxide dismutase (SOD1) G93A (mSOD1(G93A)) show that mice fed…

SOD1Glutamic AcidApoptosisMice TransgenicWinePharmacologyBiologycerebellar granule cells • apoptosis • lyophilized red wine • ASL • mSOD1G93AGeneral Biochemistry Genetics and Molecular BiologyMiceSuperoxide Dismutase-1History and Philosophy of ScienceIn vivoAnimalsHumansCells Culturedchemistry.chemical_classificationWineNeuronsReactive oxygen speciesCaspase 3Superoxide DismutaseGeneral NeuroscienceCytochrome cCytochromes cAscorbic acidSurvival AnalysisNeuroprotective AgentschemistryBiochemistryApoptosisbiology.proteinCalciumReactive Oxygen SpeciesIntracellular
researchProduct

S. Typhimurium virulence changes caused by exposure to different non-thermal preservation treatments using C. elegans

2017

The aims of this research study were: (i) to postulate Caenorhabditis elegans (C. elegans) as a useful organism to describe infection by Salmonella enterica serovar Typhimurium (S. Typhimurium), and (ii) to evaluate changes in virulence of S. Typhimurium when subjected repetitively to different antimicrobial treatments. Specifically, cauliflower by-product infusion, High Hydrostatic Pressure (HHP), and Pulsed Electric Fields (PEF). This study was carried out by feeding C. elegans with different microbial populations: E. coli OP50 (optimal conditions), untreated S. Typhimurium, S. Typhimurium treated once and three times with cauliflower by-product infusion, S. Typhimurium treated once and f…

Salmonella typhimurium0301 basic medicineSerotype030106 microbiologyHydrostatic pressureVirulenceBrassicaMicrobiologyMicrobiologyFoodborne Diseases03 medical and health sciences0404 agricultural biotechnologyPulsed Electric FieldsEscherichia coliHydrostatic PressureAnimalsCaenorhabditis elegansCaenorhabditis elegansVirulencebiologyBayes Theorem04 agricultural and veterinary sciencesGeneral Medicinebiology.organism_classificationAntimicrobial040401 food scienceAnti-Bacterial AgentsDisease Models AnimalBayesian survival analysisHigh Hydrostatic PressureSalmonella entericaSalmonella InfectionsbacteriaAntimicrobialPlant PreparationsS typhimuriumFood ScienceInternational Journal of Food Microbiology
researchProduct

Proposed use of spatial mortality assessments as part of the pesticide evaluation scheme for vector control

2013

Background: The WHO Pesticide Evaluation Scheme to evaluate the efficacy of insecticides does not include the testing of a lethal effect at a distance. A tool was developed to evaluate the spatial mortality of an insecticide product against adult mosquitoes at a distance under laboratory and field conditions. Operational implications are discussed. Methods: Insecticide paint, Inesfly 5A IGR (TM), containing two organophosphates (OPs): chlorpyrifos and diazinon, and one insect growth regulator (IGR): pyriproxyfen, was the product tested. Laboratory tests were performed using "distance boxes" with surfaces treated with one layer of control or insecticide paint at a dose of 1 kg/6 sq m. Field …

Scheme (programming language)WHOPESInsecticidesMosquito ControlBiologyToxicologyIndoor residual spraying (IRS)Insecticide paintMass effectStatisticsAnophelesInsecticide-treated nets (ITNs)Animalscomputer.programming_languageSpatial AnalysisVector controlResearchLong-lasting insecticidal nets (LLINs)insecticidal nets (LLINs)PesticideSurvival AnalysisVector controlCulexInfectious DiseasesLong-lastingParasitologycomputerField conditionsMalaria Journal
researchProduct

Effect of epidermal papillomatosis on survival of the freshwater fish Rutilus rutilus.

2004

Epidermal papillomatosis occurs in several marine and freshwater fish species. Previously, papillomatosis has been shown to induce mortality in juvenile carp. We studied the effect of epidermal papillomatosis on the survival of adult male roach Rutilus rutilus by caging naturally diseased, marked (by us) fish in the field. Within the constraints of the experimental design, there was no difference in survival between healthy, slightly diseased and heavily diseased fish. Therefore, we conclude that the possible effect of epidermal papillomatosis on the mortality of wild roach is relatively minor.

Skin Neoplasmsintegumentary systembiologyAdult malePapillomaEcologyCyprinidaeZoologyPapillomatosisAquatic Sciencebiology.organism_classificationSurvival AnalysisFish DiseasesCyprinidaemedicineFreshwater fishFish <Actinopterygii>JuvenileAnimalsRutilusmedicine.symptomCarpEcology Evolution Behavior and SystematicsFinlandDiseases of aquatic organisms
researchProduct

Sorafenib in advanced hepatocellular carcinoma

2008

none 25 BACKGROUND: No effective systemic therapy exists for patients with advanced hepatocellular carcinoma. A preliminary study suggested that sorafenib, an oral multikinase inhibitor of the vascular endothelial growth factor receptor, the platelet-derived growth factor receptor, and Raf may be effective in hepatocellular carcinoma. METHODS: In this multicenter, phase 3, double-blind, placebo-controlled trial, we randomly assigned 602 patients with advanced hepatocellular carcinoma who had not received previous systemic treatment to receive either sorafenib (at a dose of 400 mg twice daily) or placebo. Primary outcomes were overall survival and the time to symptomatic progression. Seconda…

SorafenibMaleNiacinamidemedicine.medical_specialtyCarcinoma HepatocellularPyridinesPlaceboGastroenterologyDouble-Blind MethodInternal medicinemedicineCarcinomaHumansHEPATOCELLULAR CARCINOMAProtein Kinase InhibitorsAgedNeoplasm StagingProportional Hazards Modelsbusiness.industryPhenylurea CompoundsHazard ratioBenzenesulfonatesLiver NeoplasmsGeneral MedicineTREATMENTMiddle AgedSorafenibmedicine.diseaseInterim analysisSurvival AnalysisRecurrent Hepatocellular Carcinomadigestive system diseasesSurgeryHEPATOCELLULAR CARCINOMA; SORAFENIB; TREATMENTChemotherapy AdjuvantHepatocellular carcinomaDisease ProgressionFemaleraf KinasesbusinessLiver cancermedicine.drug
researchProduct